In acute myeloid leukemia cells, the FLT3 mutation was associated with increases in c-Myc activity, USP22 levels and SIRT1 abundance and correlated with TP53 target gene repression [69]. This evidence concerns the gene FLT3 and acute myeloid leukemia.